Raises projected supply of one-dose shot to 200 million
Though difficult to believe, it has been one year since the World Health Organization declared the Covid-19 outbreak a pandemic.
Since then, there has been plenty of progress in the quest to combat the virus. In the past couple of weeks alone, key vaccine-activity developments have surfaced, including the announcement that Johnson & Johnson would be teaming up with Merck to help manufacture the J&J vaccine.
J&J chairman and CEO Alex Gorsky recently visited the White House, where President Biden announced that the US would be purchasing an additional 100 million doses of the company's Covid-19 vaccine. Last August, J&J signed an agreement with the US government to deliver 100 million doses of its vaccine—a commitment, the company says, it is on track to meet.